Evidence map›Paper›PMID 40825985›Full record

ArticleScientific reports2025

To select the optimal immunohistochemical staining method for pigmented melanoma.

Juan Lin, Zhijie You, Xin Chen

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Juan Lin *Shengli Clinical Medical College, Fujian Medical University, Fuzhou, 350001, Fujian Province, China.
Zhijie You *Shengli Clinical Medical College, Fujian Medical University, Fuzhou, 350001, Fujian Province, China.
Xin ChenShengli Clinical Medical College, Fujian Medical University, Fuzhou, 350001, Fujian Province, China. cxc1210@fjmu.edu.cn.

Funding

the Startup Fund for Scientific Research of Fujian Medical University No. 2020QH1170
6 · The paper itself

Abstract

Melanin granules may be difficult to distinguish from the brown reaction product of 3,3'-diaminobenzidine (DAB) in immunostaining. To identify a reliable immunostaining protocol for pigmented melanoma that preserves tissue integrity while enabling clear observation of antigen-antibody binding. Ki67 and the human melanoma black 45 (HMB45) immunostaining was performed on 30 pigmented melanoma specimens using three methods: (1) Unbleached control, (2) Bleached with 5% H₂O₂, (3) Alkaline Phosphatase-3-Amino-9-Ethylcarbazole (AP-AEC). Compared with the unbleached control, the coincidence rates of Ki67 and HMB45 expression in bleached with 5% H

Indexed as

ImmunohistochemistryMelanomaSkin NeoplasmsStaining and LabelingAgedBiomarkers, TumorFemaleHumansKi-67 AntigenMaleMelanoma-Specific AntigensMiddle AgedBiomarkers, TumorKi-67 AntigenMelanoma-Specific AntigensAECDABH2O2ImmunostainingMelanin bleachingPigmented melanoma

Identifiers

PMID40825985
PMCPMC12361535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.